|
WO2020048525A1
|
|
Bispecific antigen binding proteins and uses thereof
|
|
WO2020132810A1
|
|
Multispecific antigen binding proteins capable of binding cd19 and cd3, and use thereof
|
|
US2018028614A1
|
|
Use of interleukin-22 in the treatment of fatty liver disease
|
|
CN109328069A
|
|
Purposes of the IL-22 in treatment necrotizing enterocolitis
|
|
CA3017776A1
|
|
Multispecific fab fusion proteins and use thereof
|
|
EP3065763A1
|
|
Use of il-22 dimer in manufacture of a medicament for intravenous administration
|
|
CN105705160A
|
|
Use of il-22 dimers in manufacture of medicaments for treating pancreatitis
|
|
CA2842969A1
|
|
Use of g-csf dimer in preparation of medicament for treatment of neurodegenerative diseases
|
|
CN107903325A
|
|
Polyspecific FAB fusion proteins and its application method
|
|
CN103182072A
|
|
Application of interleukin-22 in treating and preventing nerve injuries and neurodegeneration diseases
|
|
CN104710535A
|
|
Recombinant human G-CSF dimmer and application thereof in treating nervous system diseases
|
|
CN102380090A
|
|
G-CSF (granulocyte-colony stimulating factor) dimmer applied to treat neutropenia
|
|
CN102380091A
|
|
Application of interleukin-22 in curing virus hepatitis
|
